Napolitano S, Ciardiello D, De Falco V, Martini G, et al. Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial. Int J Cancer 2023 Jun 30. doi: 10.1002/ijc.34632.
PMID: 37391938